Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Nelson

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid diseaseP V Ross, R J Koenig, P Arscott, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1997
Successful treatment of infantile hemangiomas with interferon-alpha-2bE Chang, A Boyd, C C Nelson, et al.
Clinical & Experimental Metastasis|October 29, 2013
PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancerI Vela, C Morrissey, X Zhang, et al.
Open Biology|November 17, 2012
Ribosomal frameshifting used in influenza A virus expression occurs within the sequence UCC_UUU_CGU and is in the +1 directionA E Firth, B W Jagger, H M Wise, et al.
Journal of Medical Genetics|November 6, 2001
Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutationsR P Erickson, S L Dagenais, M S Caulder, et al.
Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
Oncogene|January 17, 2017
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid diseaseP V Ross, R J Koenig, P Arscott, et al.
Journal of Pediatric Hematology/Oncology|May 1, 1997
Successful treatment of infantile hemangiomas with interferon-alpha-2bE Chang, A Boyd, C C Nelson, et al.
Clinical & Experimental Metastasis|October 29, 2013
PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancerI Vela, C Morrissey, X Zhang, et al.
Open Biology|November 17, 2012
Ribosomal frameshifting used in influenza A virus expression occurs within the sequence UCC_UUU_CGU and is in the +1 directionA E Firth, B W Jagger, H M Wise, et al.
Journal of Medical Genetics|November 6, 2001
Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutationsR P Erickson, S L Dagenais, M S Caulder, et al.
Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
Oncogene|January 17, 2017
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.
Pageof 7